about
Role of Complement in Autoimmune Hemolytic AnemiaTreatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive ReviewNew Insights in the Pathogenesis of Autoimmune Hemolytic AnemiaComplement inhibitors to treat IgM-mediated autoimmune hemolysisRed blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapyHaemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective.Autoimmune complications in chronic lymphocytic leukaemia (CLL).Antibodies to actin in autoimmune haemolytic anaemiaDiagnostic testing and interpretation of tests for autoimmunityA case of autoimmune hemolytic anemia with anti-D specificity in a 1-year-old child.Clearance of pathological antibodies using biomimetic nanoparticles.Pulse cyclophosphamide therapy in refractory warm autoimmune hemolytic anemia: a new perspective.CXCL13, CCL4, and sTNFR as circulating inflammatory cytokine markers in primary and SLE-related autoimmune hemolytic anemia.Red Blood Cell Transfusion in Patients With Autoantibodies: Is It Effective and Safe Without Increasing Hemolysis Risk?Elderly female with Autoimmune hemolytic anemiaPrecautions surrounding blood transfusion in autoimmune haemolytic anaemias are overestimated'Chameleonic' Serological Findings Leading to Life-Threatening Hemolytic Transfusion Reactions.Autoimmune hemolytic anemia: classification and therapeutic approaches.Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories.Classification and therapeutic approaches in autoimmune hemolytic anemia: an update.Current approaches for the treatment of autoimmune hemolytic anemia.Immunotherapy treatments of warm autoimmune hemolytic anemia.Anemia in malignancies: pathogenetic and diagnostic considerations.The effect of erythropoiesis-stimulating agents in patients with therapy-refractory autoimmune hemolytic anemia.Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice.Autoimmune hemolytic anemia and nodular lymphocyte-predominant hodgkin lymphoma: a rare association.A monocentric retrospective study comparing pulse cyclophosphamide therapy versus low dose rituximab in the treatment of refractory autoimmune hemolytic anemia in adults.[Hemolytic anemia].Methods for quantitative detection of antibody-induced complement activation on red blood cells.Warm Autoimmune Hemolytic Anemia and Direct Antiglobulin Testing With a False-Negative Result in a 53-Year-Old Man: The DAT Will Set You Free.The role of glucocorticoid in SIRP alpha and SHP-1 gene expression in AIHA patients.Atypical autoimmune hemolytic anemia.Therapy for chronic cold agglutinin disease: perspective for further improvements.Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.Acquired factor XIII deficiency: still a clinical challenge in the era of novel therapy.The diagnosis and management of primary autoimmune haemolytic anaemia.Possible Trimethoprim-Sulfamethoxazole-Induced Hemolytic Anemia: A Case Report.Acute autoimmune hemolytic anemia due to anti-Ena autoantibody successfully treated with rituximab.Significances of red cell bound immunoglobulin G as detected by flow cytometry in patients with Coombs-negative immune hemolysis.Retrospective analysis of 30 severe autoimmune hemolytic anemia patients treated by whole blood exchange transfusion.
P2860
Q26773175-8FD42331-2ADB-4037-9813-C6BEF413959CQ26773178-CCE35816-EAD3-4142-B379-55C3C9621F4FQ26773181-FEF906DB-9F16-456E-91F9-CFC816746BD4Q26777628-8B379B6B-1387-4BCD-AAB7-B6D20EBF1B19Q27013581-7253CC62-E29C-4F28-9094-F75EF41D1DEBQ33380342-5F74D04B-8349-49E6-968D-BDD87DE60D2BQ33390656-2647EBEB-A67E-4A7B-B102-F332A776E5A5Q33547686-11987B52-4D9D-413E-9DB7-ACE7A0B72FFCQ33705917-83A0AB13-B626-46B3-B19B-37F28E2FF003Q34183551-C63A3265-E772-4919-934A-5FA1567859B0Q34218004-43521BA5-A12E-441D-A44B-6E2C3BD64781Q34569003-46909AB0-4C9E-471D-AFF5-FA0B8AD8467DQ35568792-3BD2C5CC-CE8E-4A80-8614-B4C28E3AA037Q35657351-E981B073-0310-4363-ABF8-D4ABBDA4C4EFQ36159419-BB6EF76C-6119-4C6B-8F50-2ECF602DA198Q36220079-60BAF7CD-AAA5-4989-94F8-B162F9A4D605Q36369652-222B76C7-C606-46D5-BC5A-CD7BAF579BD6Q37810065-CC72B106-C27E-4C8C-89EB-C837AF6F440AQ37923504-B8760132-BBF7-4888-96FC-F3AC4B8F12F6Q37955228-B8AEDA89-757C-4880-8B67-CB606C7AD0A4Q38108152-A5F83C0E-2683-4D69-8453-17B456FF3E6AQ38150845-1A9A8007-05B8-43CE-B1D9-B22CDE116F06Q38199176-087B6690-6EC2-448F-AA4C-572FF632F30AQ38351622-C7A926F1-0036-4A9C-9CB5-23A7B86FEF1BQ38787272-BDF0833E-E526-400F-946F-95D5511C8F0FQ40246473-78AAC90C-AFE3-49C4-8BD8-6B825A2F1501Q40626008-F9C8FCFE-929A-4B2F-9E8A-7261984EFD2BQ41070320-FE20484A-3431-4B88-8867-C72C31DD434DQ41956943-DC7043B9-2A97-445D-B8AC-9467B5A05BAAQ42355234-B02BD958-8F97-4B80-8949-0A0AAA9D6BA8Q42462157-9560A14C-6A08-4B95-B875-1AAC41199D04Q42958700-E53D5E76-3257-4EFF-8FD6-805B7AB0FE02Q43195880-04C81656-5C26-4F80-8BCE-ECA7D87E31BBQ45666897-C1842C9C-9C91-4C37-B63D-281186F48A04Q45859173-623D1D98-5DBD-48E0-975D-41563C3DA6ACQ48124799-CCC95E9F-363A-432C-84C9-AFA93585020AQ50089289-8F990297-5EC4-4C99-82ED-F95EE15489A7Q50098670-D61D8003-02B4-4573-8A9B-95D8EE2069E9Q50252844-85A9B227-616E-4153-8ECF-E539CB5D31F2Q50447053-D0B5B4ED-8FFD-4B81-872D-6C68EDC57FC2
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hemolytic anemia due to warm autoantibodies.
@en
type
label
Hemolytic anemia due to warm autoantibodies.
@en
prefLabel
Hemolytic anemia due to warm autoantibodies.
@en
P1433
P1476
Hemolytic anemia due to warm autoantibodies.
@en
P2093
Charles H Packman
P356
10.1016/J.BLRE.2007.08.001
P577
2007-09-27T00:00:00Z